Oral Berotralstat Reduces the Rate of Moderate and Severe Attacks and Percentage of Days with HAE Symptoms Over 48 Weeks in Children Aged 2 to Less Than 12 Years: Interim Data from APeX-P

Journal of Allergy and Clinical Immunology 2026 Open access

Read full text
Authors: Jolanta Bernatoniene, Melisande Bourgoin‐Heck, Mauro Cancian, William Yang, Shira Benor, Anne Pagnier, Marcin Stobiecki, Stéphane Gayet, Tamar Kinaciyan, Elsa Phillips‐Anglés, Noémi‐Anna Bara, Michael DeSpirito
+4 more Douglas T Johnston, Daniel Long, Daniel Petroni, Emel Aygören‐Pürsün
DOI: 10.1016/j.jaci.2025.12.120
Cited by: 0

Fields of Study & Subjects

Coagulation Bradykinin Polyphosphates and Angioedema Hemophilia Treatment and Research Mast cells and histamine

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB39–AB39
Publication date
1 February 2026
Language
EN